EVALUATING BDNF PROTEIN AND RECEPTOR CHANGES INDUCED BY CHRONIC SYNTHETIC CANNABINOID WIN55,212-2 IN ADOLESCENT RATS

被引：0
|
作者：
Torres, A. G. [1 ]
Vazquez-Sanroman, D. [1 ]
机构：
[1] Oklahoma State Univ, Ctr Hlth Sci, Stillwater, OK 74078 USA
来源：
DRUG AND ALCOHOL DEPENDENCE | 2024年 / 261卷
关键词：
D O I：
10.1016/j.drugalcdep.2024.111185
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats
    Kirschmann, Erin K.
    McCalley, Daniel M.
    Edwards, Caitlyn M.
    Torregrossa, Mary M.
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2017, 11
  • [2] Endothelial dysfunction caused by chronic cisplatin treatment is improved by the synthetic cannabinoid, Win55,212-2
    Herradon, E.
    Gonzalez, C.
    Martin, M., I
    Lopez-Miranda, V
    HYPERTENSION, 2008, 52 (04) : 768 - 768
  • [3] Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2
    Morgese, M. G.
    Cassano, T.
    Gaetani, S.
    Macheda, T.
    Laconca, L.
    Dipasquale, P.
    Ferraro, L.
    Antonelli, T.
    Cuomo, V.
    Giuffrida, A.
    NEUROCHEMISTRY INTERNATIONAL, 2009, 54 (01) : 56 - 64
  • [4] The effects of the synthetic cannabinoid receptor agonists, WIN55,212-2 and CP55,940, on salicylate-induced tinnitus in rats
    Zheng, Yiwen
    Stiles, Lucy
    Hamilton, Emma
    Smith, Paul F.
    Darlington, Cynthia L.
    HEARING RESEARCH, 2010, 268 (1-2) : 145 - 150
  • [5] Pharmacologically induced hypothermia with cannabinoid receptor agonist WIN55,212-2 after cardiac arrest
    Rungatscher, A.
    Linardi, D.
    Giacomazzi, A.
    Milani, E.
    Hallstroem, S.
    Mazzucco, A.
    Faggian, G.
    EUROPEAN HEART JOURNAL, 2012, 33 : 638 - 638
  • [6] The Synthetic Cannabinoid WIN55,212-2 Can Disrupt the Golgi Apparatus Independent of Cannabinoid Receptor-1S
    Lott, Joshua
    Jutkiewicz, Emily M.
    Puthenveedu, Manojkumar A.
    MOLECULAR PHARMACOLOGY, 2022, 101 (05) : 371 - +
  • [7] The Synthetic Cannabinoid Agonist, WIN55,212-2, Inhibits Jejunal Afferent Responses to LPS in a Cannabinoid-Receptor Independent Manner
    Donovan, Jemma
    Grundy, David
    GASTROENTEROLOGY, 2009, 136 (05) : A725 - A725
  • [8] Behavioral and Neurochemical Changes in Mesostriatal Dopaminergic Regions of the Rat after Chronic Administration of the Cannabinoid Receptor Agonist WIN55,212-2
    Fanarioti, Eleni
    Mavrikaki, Maria
    Panagis, George
    Mitsacos, Ada
    Nomikos, George G.
    Giompres, Panagiotis
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (06): : 1 - 17
  • [9] The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets
    Simoneau, II
    Hamza, MS
    Mata, HP
    Siegel, EM
    Vanderah, TW
    Porreca, F
    Makriyannis, A
    Malan, TP
    ANESTHESIOLOGY, 2001, 94 (05) : 882 - 887
  • [10] The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
    Bridges, D
    Ahmad, K
    Rice, ASC
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (04) : 586 - 594
12345